Baxter Hillrom Acquisition Presentation
Baxter at a glance
Leadership
Established leadership position
across portfolio
2020 Revenue by Business¹
Global Opportunity
Optimizing resources across
portfolio
Total
$11.7B
Biopharma Solutions
$0.5B
Acute
Therapies
$1B+
Global Category Size & Growth²
% CAGR
4% -5%
Acute Therapies
$0.7B
Advanced Surgery
$0.9B
Advanced
Surgery
$3B+
4% -5%
Clinical Nutrition
$0.9B
Pharmaceuticals
$2.1B
Clinical
Nutrition
$4B+
~1%
Pharmaceuticals
Medication Delivery
$2.7B
Baxter
$55B+
3% -4%
Medication
Delivery
$23B+
~2%
Renal Care
$3.8B
Digital Transformation
Enabling a digital operating model
to deliver digital solutions
Digital Health
Data-driven products,
personalized care
Renal
Care
$13B+
TAM³: $100B+
~4%
WAMGR4: ~3%
1Fiscal year ended 12/31/2020. Total revenue includes $0.1B of Other revenue not presented above. 2Global category size based on internal estimates for
2021. Reflects 2021E-2024E growth rates. ³TAM represents total addressable market. 4WAMGR represents weighted average market growth rate.
Digital Customer
Experience
Connected and simplified
experiences
Digital Core
Smarter, faster
end-to-end processes
H' Hillrom..
CO
6View entire presentation